retatrutide clinical trial retatrutide drug ⚠️ “RETA” is NOT an approved weight-loss medication. Social media is full of “RETA” offers—but here's what you should know. is a promising investigational medicine developed by Eli Lilly. The Phase Retatrutide Research: Triple Agonist Mechanism

This sustained sensitivity may explain why some individuals report consistent benefits from low doses maintained over many months

Luginbuhl A, Kahue CN, Stewart M, Curry JM, Weed D, Zender C, Netterville J, Zafereo ME

This dual mechanism provides: GLP-1 receptor activation: Enhanced glucose-stimulated insulin secretion, slowed gastric emptying, and increased satiety signaling GIP receptor activation: Additional insulin secretion support and potential effects on lipid metabolism and fat deposition Tirzepatide gained regulatory approval in 2023 and has been extensively studied in Phase 3 clinical trials with larger patient populations and longer durations

This can lead to aesthetic concerns like Ozempic Face. If you are a patient, always work with a doctor

Who May Be a Candidate for Tesamorelin